en
Scientific article
English

Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type

Published inNeurobiology of Aging, vol. 36, no. 2, p. 601-607
Publication date2015
Abstract

Increased peripheral and central nervous system cortisol levels have been reported in Alzheimer's disease (AD) and may reflect dysfunction of cerebral components of the hypothalamic-pituitary-adrenal (HPA) axis. However, brain exposure to high cortisol concentrations may also accelerate disease progression and cognitive decline. The objectives of this study were to investigate whether HPA-axis dysregulation occurs at early clinical stages of AD and whether plasma and CSF cortisol levels are associated with clinical disease progression. Morning plasma and CSF cortisol concentrations were obtained from the subjects with AD dementia, mild cognitive impairment of AD type (MCI-AD), MCI of other type (MCI-O), and controls with normal cognition included in a multicenter study from the German Dementia Competence Network. A clinical and neuropsychological follow-up was performed in a subgroup of participants with MCI-AD, MCI-O, and AD dementia. CSF cortisol concentrations were increased in the subjects with AD dementia or MCI-AD compared with subjects with MCI-O or normal cognition. After controlling for possible confounders including CSF measures of amyloid beta1-42 and total tau, higher baseline CSF cortisol levels were associated with faster clinical worsening and cognitive decline in MCI-AD. The findings suggest that HPA-axis dysregulation occurs at the MCI stage of AD and may accelerate disease progression and cognitive decline.

Keywords
  • Aged
  • Alzheimer Disease/blood/cerebrospinal fluid/diagnosis/physiopathology
  • Amyloid beta-Peptides/cerebrospinal fluid
  • Biomarkers/blood/cerebrospinal fluid
  • Cognitive Dysfunction/blood/cerebrospinal fluid/diagnosis/physiopathology
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocortisone/blood/cerebrospinal fluid
  • Hypothalamo-Hypophyseal System/physiopathology
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Peptide Fragments/cerebrospinal fluid
  • Pituitary-Adrenal System/physiopathology
  • tau Proteins/cerebrospinal fluid
Affiliation Not a UNIGE publication
Citation (ISO format)
POPP, Julius et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer’s type. In: Neurobiology of Aging, 2015, vol. 36, n° 2, p. 601–607. doi: 10.1016/j.neurobiolaging.2014.10.031
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0197-4580
346views
0downloads

Technical informations

Creation06/08/2018 10:17:00 AM
First validation06/08/2018 10:17:00 AM
Update time03/15/2023 8:26:34 AM
Status update03/15/2023 8:26:33 AM
Last indexation01/17/2024 3:14:29 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack